Abstract
The excitotoxins kainic acid and N-methyl d-aspartate (NMDA) were unilaterally injected in the rat striatum. Kainic acid injections resulted in a widespread pattern of Fos protein induction, mainly involving cortical olfactory structures and hippocampus. Immunoreactive cells were observed in large number 2–24 h after injection and had almost completely disappeared by 48 h. NMDA injections elicited a shorter (2–8 h) expression of Fos protein, involving a lower number of cells in cortical olfactory structures, a much larger number of cells in the other cortical regions, and not involving the hippocampus at all. Characteristically none of the two excitotoxins stimulated Fos expression from striatal neurons, even in the close vicinity of the needle tract. In addition to striatal lesions almost equivalent in size, the two excitotoxins caused distant lesions of different extension: kainic acid resulted in extensive neuronal degeneration in the olfactory-entorhinal cortices and among pyramidal neurons of the hippocampus; NMDA caused a less widespread neurodegeneration, restricted to the olfactory cortex. Administration of the competitive NMDA antagonist CGP 39551 largely prevented the distant, but not the local, neuropathological changes caused by intrastriatal kainic acid or NMDA. The expression of Fos protein, however, was partially prevented only in NMDA cases. The present results show a good relationship between the spreading of circuit overexcitation caused by the two excitotoxins and the regional and temporal patterns of Fos expression. The relationship between Fos expression and neuropathological condition remains, however, elusive.
Similar content being viewed by others
References
Aronin N, Chase K, Sagar SM, Sharp FP, DiFiglia M (1991) N-methyl-d-aspartate receptor activation in the neostriatum increases c-fos and Fos-related antigens selectively in medium-sized neurons. Neuroscience 44:409–420
Ben-Ari Y, Tremblay E, Ricke D, Ghilini G, Naquet R (1981) Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or phentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6:1361–1391
Berretta S, Robertson HA, Graybiel AM (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J Neurophysiol 68:767–777
Brennan PA, Hancock D, Keverne EB (1992) The expression of the immediate-early genes c-fos, egr-1 and c-jun in the accessory olfactory bulb during the formation of an olfactory memory in mice. Neuroscience 49:277–284
Campbell-Teskey G, Atkinson BG, Cain DP (1991) Expression of the proto-oncogene c-fos following electrical kindling in the rat. Brain Res Mol Brain Res 11:1–10
Clifford DB, Olney JW, Benz AM, Fuller TA, Zorumski CF (1990) Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia 31:382–390
Cole AJ, Saffen DW, Baraban JM, Worley PF (1989) Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 340:474–476
Coyle JT (1983) Neurotoxic action of kainic acid. J Neurochem 41:1–11
Curran T, Franza BR (1988) Fos and Jun: the AP1 connection. Cell 55:395–397
Curran T, Morgan JI (1985) Superinduction of fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science 229:1265–1268
Facchinetti F, Virgili M, Contestabile A, Barnabei O (1992) Antagonists of the NMDA receptor and allopurinol protect the olfactory cortex but not the striatum after intra-cerebral injection of kainic acid. Brain Res 585:330–334
Fariello RG, Golden GT, Smith GG, Reyes PF (1989) Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res 3:206–213
Foster AC, Gill R, Kemp JA, Woodruff GN (1987) Systemic administration of MK-801 prevents N-methyl-d-aspartate-induced neuronal degeneration in rat brain. Neurosci Lett 76:307–311
Foster AC, Gill R, Woodruff GN (1988) Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J Neurosci 8:4745–4754
Gass P, Herdengen T, Bravo R, Kiessling M (1992) Induction of immediate early gene encoded proteins in the rat hippocampus after bicuculline-induced seizures: differential expression of Krox-24, Fos and Jun protein. euroscience 48:315–324
Guarnieri T, Virgili M, Villani L, Facchinetti F, Contestabile A, Migani P (1993) Pharmacological manipulation of the NMDA receptor differentially protects from systemic kainic acid neuropathology: evaluation through ornithine decarboxylase induction, morphology and GFAP immunohistochemistry. Restor Neurol Neurosci 5:327–335
Herrera DG, Robertson HA (1990) N-methyl-d-aspartate receptors mediate activation of c-fos proto-oncogene in a model of brain injury. Neuroscience 35:273–281
Herrling PL (1993) Competitive NMDA antagonists: results in animal models and first results in humans. J Neurochem [Suppl]61:S283
Hunt SP, Pini A, Evan G (1987) Induction of c-fos protein in spinal cord neurons following sensory stimulation. Nature 328:632–634
Jorgersen MB, Deckert J, Wright DC, Gehlert DR (1989) Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study. Brain Res 484:393–398
Kruijer W, Schubert D, Verma I (1985) Induction of the proto-oncogene c-fos by nerve growth factor. Proc Natl Acad Sci USA 82:7330–7334
Le Gal La Salle G (1988) Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus. Neurosci Lett 88:127–130
Morgan JI, Curran T (1986) The role of ion flux in the control of c-fos expression. Nature 322:552–555
Morgan JI, Curran T (1991) Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogene fos and jun. Annu Rev Neurosci 14:421–451
Morgan JI, Cohen DC, Hempstead JL, Curran T (1987) Mapping patterns of c-fos expression in the central nervous system after seizures. Science 237:192–197
Olney JW (1981) Kainic acid and other excitotoxins: a comparative analysis. In: Chiara G, Gessa GL (eds) Glutamate as a neurotransmitter. Raven, New York, pp 375–384
Olney GW, Ho OL, Rhee V (1974) Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 77:507–512
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic, Sidney
Popovici T, Represa A, Crèpel V, Barbin G, Beaudoin M, Ben-Ari Y (1990) Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res 536:183–194
Robertson GS, Vincent SR, Fibiger HC (1990) Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res 523:288–290
Rothman SM, Olney JW (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci 10:399–410
Sagar MS, Sharp FS, Curran T (1988) Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240:1328–1331
Schilling K, Curran T, Morgan JI (1991) The excitement of immediate-early genes. Ann NY Acad Sci 627:115–123
Schmutz M, Portet C, Jeker A, Klebs K, Vassout A, Allgeier H, Heckendorn N, Fagg GE, Olpe HR, Riezen H van, (1990) The competitive NMDA receptor antagonists CGP37849 and CGP39551 are potent, orally active anticonvulsants in rodents. Naunyn Schmiedebergs Arch Pharmacol 342:61–66
Schwob JE, Fuller T, Price JL, Olney JW (1980) Widespread patterns of neuronal damage following systemic or intracerebral injection of kainic acid: a histological study. Neuroscience 5:991–1014
Sharp FR, Gonzalez MF, Hianaga K, Mobley WC, Sagar SM (1989) Induction of the c-fos gene product in rat forebrain following cortical lesions and NGF injections. Neurosci Lett 100:117–122
Sonnenberg JL, Mitchlmore C, Macgregor-Leon PF, Hempstead J, Morgan JI, Curran T (1989) Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. J Neurosci Res 24:72–80
Vendrell M, Zawia NH, Serratosa J, Bondy SC (1991) C-fos and ornithine decarboxylase gene expression in brain as early markers of neurotoxicity. Brain Res 544:291–296
Virgili M, Migani P, Contestabile A, Barnabei O (1992) Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP-39551 on neurotransmitter and glial markers. Neuropharmacology 31:469–474
Wessel TC, Joh TH, Volpe BT (1991) In situ hybridization analysis of c-fos and c-jun expression in the rat brain following transient forebrain ischemia. Brain Res 567:231–240
Wood H, Belleroche J de (1991) Induction of c-fos mRNA in cerebral cortex by excitotoxin stimulation of cortical inputs: involvement of N-methyl-d-aspartate receptors. Brain Res 545:183–190
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ciani, E., Guarnieri, T. & Contestabile, A. Fos protein induction, neuropathology, and pharmacological protection after excitotoxic brain insult. Exp Brain Res 98, 421–430 (1994). https://doi.org/10.1007/BF00233980
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00233980